vcfirmsdirectory.com

Venture capital · Early stage

Advent Life Sciences

London-based trans-Atlantic venture firm that backs and builds life sciences companies, from drug discovery to medtech, across the UK, Europe and the USA.

LondonRegistered · London
New investments · 12 months
Fund vehiclesPublic
12
7 active · US private fund · EuVECA
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:05 CETSources: ESMA register · adventls.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Advent Life Sciences joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Advent Life Sciences right for your round?

Is Advent Life Sciences a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
12
7 active · US private fund · EuVECA
ESMA register and SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (ESMA register and SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ADVENT LIFE SCIENCES FUND I LPUS private fund · Active · United Kingdom · $246.7M gross assets · filed 26 Mar 2026
ADVENT LIFE SCIENCES GROWTH FUND LPUS private fund · Active · United Kingdom · $170.8M gross assets · filed 26 Mar 2026
ADVENT LIFE SCIENCES FUND II LPUS private fund · Active · United Kingdom · $159.2M gross assets · filed 26 Mar 2026
ADVENT LIFE SCIENCES FUND III LPUS private fund · Active · United Kingdom · $154.1M gross assets · filed 26 Mar 2026
ADVENT-HARRINGTON IMPACT FUND LPUS private fund · Active · United Kingdom · $52.2M gross assets · filed 26 Mar 2026
BIOMOTIV LLCUS private fund · Active · United States · $27.9M gross assets · filed 26 Mar 2026
ADVENT LIFE SCIENCES II CO-INVEST LPUS private fund · Active · United Kingdom · $18.6M gross assets · filed 26 Mar 2026
Advent Life Sciences Fund I LPEuVECA · Inactive · United Kingdom
Advent Life Sciences Fund II LPEuVECA · Inactive · United Kingdom
Advent Life Sciences Fund III LPEuVECA · Inactive · United Kingdom
Advent Life Sciences II Co-Invest LPEuVECA · Inactive · United Kingdom
Advent-Harrington Impact Fund LPEuVECA · Inactive · United Kingdom
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Advent Life Sciences joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Advent Life Sciences joined

Round sizes, Advent Life Sciences’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AcutusAgenusALETAAlgetaAlphaRose TherapeuticsAmphistaAraviveArgá MedtechArrakisArtaxand 47 more

Portfolio and exits

Every company Advent Life Sciences backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Advent Life Sciences puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Advent Life Sciences

Events where Advent Life Sciences’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Advent Life Sciences’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

26 Mar 2026Fund filingForm ADV filed by ADVENT LIFE SCIENCES LLP: 7 private funds, $829.5M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Advent Life Sciences is based in London, United Kingdom.

12 fund vehicles are on public registers (ESMA register and SEC adviser filings), including ADVENT LIFE SCIENCES FUND I LP, ADVENT LIFE SCIENCES GROWTH FUND LP and ADVENT LIFE SCIENCES FUND II LP.

Stages: Seed, Early stage, Series A. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.

Advent backs groundbreaking science early, often at Seed or Series A, and works hands-on with founders to turn it into approved medicines or products. It targets first-in-class or best-in-class opportunities and helps shape scientific approach, operating plan, team, syndication and financing. From the firm’s own website.

Advent Life Sciences lists 57 portfolio companies on its website, including Acutus, Agenus, ALETA, Algeta and AlphaRose Therapeutics.

Firms whose websites list some of the same companies include Monograph Capital, 1kx and 359 Capital.

Know before Advent Life Sciences’s next round is announced.

PRO tracks Advent Life Sciences’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Advent Life SciencesGet Advent Life Sciences’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.